US Biopreservation Market Research Report By Application (Cell and Tissue Culture, Gene and Drug Therapy, Clinical Applications, Regenerative Medicine), By Product Type (Biopreservation Media, Freezers, Cryogenic Storage Systems, Accessories), By End User (Biotechnology Companies, Pharmaceutical Companies, Research Institutions, Hospitals, Clinics) and By Storage Type (Cryopreservation, Controlled Rate Freezing, Ultra-Low Temperature Storage) - Forecast to 2035

US Biopreservation Market Overview

As per MRFR analysis, the US Biopreservation Market Size was estimated at 1.99 (USD Billion) in 2023. The US Biopreservation Market Industry is expected to grow from 2.08(USD Billion) in 2024 to 3.47 (USD Billion) by 2035. The US Biopreservation Market CAGR (growth rate) is expected to be around 4.753% during the forecast period (2025 - 2035).

Key US Biopreservation Market Trends Highlighted

The US Biopreservation Market is experiencing significant trends driven by a combination of technological advancements and increasing demand for biologics. The rise in biotechnology and life sciences, particularly in cell and gene therapies, is a key market driver, as these therapies require effective biopreservation methods to maintain the viability of cells and tissues. Additionally, the growing focus on personalized medicine is encouraging the development of tailored biological products, thereby increasing the need for efficient biopreservation solutions. Opportunities to be explored include the expansion of biobanks and the increased emphasis on regenerative medicine.

Biobanks play a vital role in research by storing biological samples that require precise preservation to ensure their longevity and effectiveness in studies. Furthermore, as the US healthcare system shifts towards value-based care, there is a greater emphasis on the conservation of therapeutic products, allowing biopreservation techniques to gain traction. Recent trends indicate a heightened interest in advanced biopreservation techniques, such as cryopreservation and lyophilization. These methods not only enhance the stability of biological samples but also align with the need for improved storage solutions in the face of logistical challenges.

Regulatory support from agencies like the FDA also plays an important role in paving the way for innovations in biopreservation methods, assuring end-users regarding the safety and efficacy of preserved product

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Biopreservation Market Drivers

Increasing Demand for Biopreservation in Clinical Trials

The US Biopreservation Market Industry is experiencing significant growth due to the increasing number of clinical trials, particularly in the fields of oncology and precision medicine. According to the National Institutes of Health (NIH), the number of clinical trials in the United States has grown substantially, with over 300,000 active trials registered in 2023. This surge is driven by the need for innovative therapies and the focus on personalized medicine, which require the storage of biological samples under optimal conditions to maintain their integrity.

Companies like Thermo Fisher Scientific and Sartorius provide biopreservation solutions that facilitate the storage and transport of these biological materials, enabling researchers to conduct their work more efficiently. The expansion of clinical trials not only creates a demand for advanced biopreservation technologies but also increases collaboration between research institutions and biobanks, further propelling the market forward.

Advancements in Biopreservation Technologies

Technological advancements in biopreservation methods such as cryopreservation and lyophilization have greatly influenced the US Biopreservation Market Industry. For instance, the introduction of automated cryopreservation systems has improved reproducibility and efficiency in sample storage, making it easier for laboratories to manage large biobanks. The Federal Drug Administration (FDA) regulations encourage the adoption of these technologies, thereby enhancing safety and performance.

Furthermore, organizations like the American Association of Blood Banks promote the use of innovative preservation techniques, which are critical in ensuring the viability of stem cells and various biomaterials. As a result, these advancements not only support ongoing research but also lead to increased market growth.

Rising Prevalence of Chronic Diseases

The US Biopreservation Market Industry benefits from the rising prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders. According to the Centers for Disease Control and Prevention (CDC), nearly 60% of adults in the United States live with a chronic illness. This alarming trend has driven healthcare providers to explore innovative treatments, thus increasing the need for biobanking and biopreservation to store biological samples and tissues.

Organizations such as the American Cancer Society play a pivotal role in funding and promoting research on cancer, further necessitating effective biopreservation methods to ensure sample integrity. As chronic diseases become a larger health concern, the demand for biopreservation solutions aimed at aiding research and therapy development continues to grow.

Support from Government Initiatives and Funding

Government initiatives and funding are substantial drivers for the growth of the US Biopreservation Market Industry. Various government agencies, including the NIH and the FDA, are actively supporting research and development in the field of biopreservation through grants and funding programs. For instance, the NIH invests billions of dollars annually in various research activities, which often involve biobanking and the use of preserved biological samples.

Additionally, recent policy changes aimed at advancing biomedical research, such as the US government's commitment to enhance data preservation in research settings, have driven investment into biopreservation technologies. This government backing not only facilitates innovation but also encourages the participation of private sector companies to develop and improve biopreservation methods, further boosting the market.

US Biopreservation Market Segment Insights

Biopreservation Market Application Insights

The Application segment of the US Biopreservation Market plays a crucial role in the overall landscape, enabling advancements across various healthcare domains. The increasing focus on cell and tissue culture has propelled its importance, driven by rising demand for effective treatment solutions in regenerative medicine. As this field grows, the need for reliable biopreservation techniques to maintain cellular viability becomes more evident, leading to improved patient outcomes. Similarly, gene and drug therapy applications are gaining momentum due to their potential to target genetic disorders, which consequently underlines the significance of robust preservation protocols to ensure the efficacy of therapeutic products.

The regulatory landscape in the United States further enhances the necessity for stringent biopreservation methods in clinical applications, where maintaining the integrity of biological materials is paramount. Moreover, the growing emphasis on research and development (R&D) within regenerative medicine is expected to boost the associated biopreservation needs, making it a dynamic area of investment. The US has observed a surge in initiatives aimed at exploring novel biopreservation techniques, accentuated by collaboration between academic institutions and industry leaders.

This convergence leads to innovative solutions tailored to specific applications, thus showcasing the importance of the Application segment in driving the future trajectory of the US Biopreservation Market. With a diverse range of applications, the market is well-positioned to respond to the evolving demands of healthcare and biotechnological advancements.

 

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Biopreservation Market Product Type Insights

The US Biopreservation Market showcases a diverse array of product types essential for maintaining biological samples. Among these, Biopreservation Media plays a crucial role by providing the necessary environment for cell cultures, tissues, and organs, enabling researchers to ensure the viability and functionality of biological materials. Freezers are equally significant, designed to preserve samples at ultra-low temperatures, thus preventing cellular degradation. Cryogenic Storage Systems further enhance preservation efforts, offering long-term storage solutions that maintain the integrity of valuable biological materials, critical for Research and Development initiatives.

Accessories such as vials, pipettes, and storage containers are equally indispensable, supporting the efficient handling and tracking of samples. As the US Biopreservation Market grows, driven by advancements in biotechnology and increasing demand for regenerative medicine, each product type will continue to play a vital role in enhancing the overall effectiveness and reliability of biopreservation practices. The market data indicates an ongoing trend toward innovation, which will further propel the segmentation within this industry.

Biopreservation Market End User Insights

The End User segment of the US Biopreservation Market encompasses various critical entities that greatly contribute to the advancement of the industry. Biotechnology companies play a pivotal role by utilizing biopreservation methods to maintain the viability of biological materials for research and product development. Pharmaceutical companies increasingly rely on biopreservation techniques to ensure the integrity of their drugs, particularly in the context of personalized medicine and complex biologics. Research institutions leverage these methods to preserve biological samples for ongoing research, which contributes significantly to scientific innovations.

Moreover, hospitals and clinics are key players, as they utilize biopreservation for the storage of blood, tissues, and organs, which enhances patient care and treatment outcomes. The rising focus on regenerative medicine and cellular therapies strengthens the demand within these sectors, particularly for safe and effective storage solutions. With the growth of these end-users, the US Biopreservation Market is poised for considerable developments, aligning with increasing research activities and advancements in healthcare technologies. The segment demonstrates robust growth potential as it adapts to the evolving needs of various industries.

Biopreservation Market Storage Type Insights

The Storage Type segment of the US Biopreservation Market encompasses various methods crucial for preserving biological materials, each playing a significant role in the healthcare and research fields. Cryopreservation is a dominant technique that allows for the long-term storage of cells, tissues, and organs by freezing them at very low temperatures, thereby maintaining their viability for future use. This method is essential for ensuring the availability of stem cells and reproductive cells for fertility treatments and transplants. Controlled Rate Freezing allows for precise temperature management during the freezing process, reducing the formation of ice crystals that can damage biological samples, which is particularly crucial in the preservation of sensitive tissues and organs.

Ultra-Low Temperature Storage operates at extreme sub-zero conditions, providing a stable environment for the preservation of a wide array of biomaterials. The increasing demand for these storage solutions is driven by advancements in Research and Development, expanding biobanks, and the growing field of regenerative medicine. Each method not only supports diverse applications in clinical settings but also enhances Research and Development opportunities, aligning with the broader US Biopreservation Market growth trends. Ensuring the integrity and viability of stored biological materials remains paramount as the industry continues to evolve.

US Biopreservation Market Key Players and Competitive Insights

The US Biopreservation Market is characterized by a rapidly evolving landscape that is shaped by advancements in technology, increasing demand for biopreserved products, and a rising awareness of the importance of cell and tissue preservation. Key participants in this market include biopharmaceutical companies, research institutions, and clinical laboratories, which rely on biopreservation solutions to extend the shelf life and maintain the integrity of biological samples. As the demand for personalized medicine and regenerative therapies continues to grow, the competitive insights reveal a market where innovation, strategic partnerships, and mergers and acquisitions play crucial roles in ensuring companies can adapt to the changing environment and meet regulatory challenges. The focus lies on developing and improving biopreservation materials, methodologies, and storage techniques that cater to the unique needs of various sectors within the life sciences, leading to a competitive edge for players who can successfully harness these advancements.

Lonza has established a strong foothold in the US Biopreservation Market, with notable strengths in its extensive portfolio of biopreservation products and services. The company leverages its deep expertise in cell and gene therapy, offering solutions that cater to the unique needs of researchers and biopharmaceutical manufacturers. Lonza's robust infrastructure allows for efficient scaling of biopreservation solutions, positioning it advantageously against competitors. Their commitment to innovation is evident through ongoing research and development initiatives aimed at creating next-generation preservation techniques that enhance sample viability and functionality. Furthermore, Lonza's established relationships with leading biotech firms and research institutions facilitate collaboration and knowledge exchange, bolstering its visibility and influence in the US market.

ReproCELL has also made significant inroads into the US Biopreservation Market, primarily focusing on cell-based assays and stem cell technologies. Known for its specialized services, the company offers a comprehensive range of biopreservation solutions tailored for cell lines, tissues, and organs. This enables them to address the specific needs of customers in regenerative medicine and drug discovery sectors. ReproCELL has acquired other companies in recent years to bolster its service offerings, enhancing its position in the market and expanding its technological capabilities. These strategic mergers and acquisitions have allowed ReproCELL to combine expertise and resources, enabling it to better serve the US market. With a focus on innovation, the company is committed to providing advanced biopreservation solutions that ensure the quality and longevity of biological samples, thus solidifying its competitive advantage in this burgeoning sector.

Key Companies in the US Biopreservation Market Include

• Lonza


• ReproCELL


• Tecan


• Bluebird Bio


• Thermo Fisher Scientific


• Fresenius Kabi


• Corning


• Vitae Health


• Cytiva


• Pall Corporation


• Biolife Solutions


• Asymptote


• Sartorius


• Merck KGaA


• SigmaAldrich

US Biopreservation Market Industry Developments

Recent developments in the US Biopreservation Market highlight significant growth potential and activity among key players such as Lonza, ReproCELL, Tecan, Bluebird Bio, Thermo Fisher Scientific, Fresenius Kabi, Corning, Vitae Health, Cytiva, Pall Corporation, Biolife Solutions, Asymptote, Sartorius, Merck KGaA, and SigmaAldrich. In February 2023, Thermo Fisher Scientific acquired PPD, enhancing its capabilities in biopreservation and increasing service offerings. Additionally, in April 2023, Pall Corporation announced a partnership with Cytiva to improve biopharmaceutical workflows, showcasing collaborative advancements in the sector. The market has seen a valuation increase of over 10% in just the past year, partly driven by rising demand for biopreservation solutions in biobanks and research institutions. Regulatory support from the U.S. Food and Drug Administration has also streamlined processes for biopreservation technologies, aiding market growth. In the last 2-3 years, significant investments in Research and Development have been noted in organizations such as Merck KGaA and Fresenius Kabi, further driving innovation and improving biopreservation methodologies. Overall, the US Biopreservation Market remains dynamic, with numerous collaborations and acquisitions shaping its future trajectory.

US Biopreservation Market Segmentation Insights

Biopreservation Market Application Outlook

• Cell and Tissue Culture


• Gene and Drug Therapy


• Clinical Applications


• Regenerative Medicine

Biopreservation Market Product Type Outlook

• Biopreservation Media


• Freezers


• Cryogenic Storage Systems


• Accessories

Biopreservation Market End User Outlook

• Biotechnology Companies


• Pharmaceutical Companies


• Research Institutions


• Hospitals


• Clinics

Biopreservation Market Storage Type Outlook

• Cryopreservation


• Controlled Rate Freezing


• Ultra-Low Temperature Storage

=

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	1.99(USD Billion)
MARKET SIZE 2024	2.08(USD Billion)
MARKET SIZE 2035	3.47(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	4.753% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Lonza, ReproCELL, Tecan, Bluebird Bio, Thermo Fisher Scientific, Fresenius Kabi, Corning, Vitae Health, Cytiva, Pall Corporation, Biolife Solutions, Asymptote, Sartorius, Merck KGaA, SigmaAldrich
SEGMENTS COVERED	Application, Product Type, End User, Storage Type
KEY MARKET OPPORTUNITIES	Increased demand for organ transplants, Growth in biobanking services, Advancements in preservation technologies, Rising focus on personalized medicine, Expansion of regenerative medicine applications
KEY MARKET DYNAMICS	increasing demand for organ transplants, advancements in cryopreservation technologies, rising prevalence of chronic diseases, regulatory advancements in biopreservation, growing biobanking initiatives
COUNTRIES COVERED	US